Skip to main content

Year: 2020

Allegro MicroSystems to Participate in Wells Fargo and Credit Suisse Investor Conferences

MANCHESTER, N.H., Nov. 24, 2020 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (NASDAQ: ALGM), a global leader in sensing and power semiconductor technology, announced today that President & Chief Executive Officer, Ravi Vig, will participate in two upcoming virtual investor conferences. The first, the 2020 Wells Fargo TMT Summit, will take place virtually on December 2, 2020, where Mr. Vig will participate in a fireside chat at 11:20 a.m. Eastern time. The second, the virtual Credit Suisse 24th Annual Technology Conference, will take place on December 3, 2020, where Mr. Vig will participate in a fireside chat at 1:30 p.m. Eastern time.The live audio webcasts for these conferences can be accessed through the Investor Relations section of Allegro’s website (https://investors.allegromicro.com). Archived replays of...

Continue reading

Bespoke Extracts Unveils Fresh New Brand Identity, Website and Line-Up of New CBD Formulations

SUNNY ISLES, Fla., Nov. 24, 2020 (GLOBE NEWSWIRE) — Bespoke Extracts, Inc. (OTC Pink: BSPK), producer of high quality, hemp-derived CBD products, today announced the official unveiling of its new corporate brand identity, redesigned logo and revamped website. In addition, the Company introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store.Bespoke Extracts CEO Danny Pollack stated, “In step with the emergence and rapid evolution of the CBD industry over the past three years, Bespoke has continued to change and mature, as well. When I came onboard earlier this year, I challenged our team to carefully evaluate our values as an organization and our collective aspirations for our Company. This process resulted in the decision to create a fresh, new brand...

Continue reading

iFresh Announces Fiscal Second Quarter 2020 Financial Results

NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) — iFresh, Inc. (“iFresh” or the “Company”) (Nasdaq: IFMK), a leading Asian American grocery supermarket chain and online grocer, announced the financial results for its fiscal second quarter ended September 30, 2020.For the second quarter 2020, the Company achieved total net sales of $24.2 million and gross profit of $4.8 million, a slight increase from the same quarter of 2019. The adjusted loss before income tax, depreciation and amortization was $2.4 million, resulting from the acquisition of Jiuxiang Blue Sky Technology (Beijing) Co., Ltd. (“Jiuxiang”) which had a net loss of $2.2 million. Founded in 2019, Jiuxiang is an emerging e-commerce enterprise in China and still in the early-growth stage. A key part of business strategy of Jiuxiang is to transform the supply chain financial service...

Continue reading

IDEX Biometrics – Notice of Extraordinary General Meeting on 15 December 2020

IDEX Biometrics ASA will hold an extraordinary general meeting on Tuesday 15 December 2020 at 12.00 hours CET. The meeting will be held as an online (digital) meeting.Key agenda items:– Election of Board of Directors– Approval of Indemnification Agreements– Approval of 2020 Subscription Rights Incentive Plan document– Authorization to the Board to issue new shares– Authorization to the Board to acquire own sharesThe notice with attendance form will be sent to the shareholders today and is also enclosed in pdf file (link).Notice in English:  2076 IDEX EGM Notice ENG_webNotice in Norwegian:  2076 IDEX EGM Notice NOR_webThe notice of the extraordinary general meeting and appendices 1 and 2 are available at the company’s web site, www.idexbiometrics.com, and can be requested from the company at no charge from...

Continue reading

PolyPid Granted Breakthrough Therapy Designation from FDA for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Colorectal Surgery

PETAH TIKVA, Israel, Nov. 24, 2020 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary PLEX technology, today announced that D-PLEX100 has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the prevention of surgical site infections (SSIs) in patients undergoing elective colorectal surgery.Breakthrough Therapy Designation is an FDA process designed to expedite the development and review of drugs that are intended to treat a serious or life-threatening condition so patients may have access to therapies through FDA approval as soon as possible. This designation is granted based on preliminary clinical evidence indicating that the drug...

Continue reading

Correction: Forventede udbytter 2020 for Investeringsforeningen Sparinvest

Med henvisning til fondsbørsmeddelelse udsendt tidligere i dag korrigerer ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg, hermed oversigten over forventede udbytter for 2020 for afdelinger og andelsklasser i Investeringsforeningen Sparinvest, da den tidligere offentliggjorte oversigt indeholdte en forkert sats for afdelingen INDEX Japan Value KL.Udbytterne er foreløbige og ureviderede. Det skal derfor fremhæves, at de endelige udbytter kan ændre sig i forhold til de forventede udbytter.De endelige udbytter forventes at blive offentliggjort og udbetalt medio februar 2021.De forventede, optjente udbytter er vist i nedenstående tabel. Tallene er beregnet pr. 19. november 2020 og opgjort i kr. pr. investeringsbevis.Henvendelser vedrørende nærværende fondsbørsmeddelelse kan rettes til Senior Client Manager Helle Skovgaard, tlf.nr. 36...

Continue reading

Progressive Reports October 2020 Results

MAYFIELD VILLAGE, OHIO, Nov. 24, 2020 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for October 2020: See Progressive’s complete monthly earnings release, including the “Monthly Commentary,” for additional information.About ProgressiveThe Progressive Group of Insurance Companies makes it easy to understand, buy and use auto insurance. Progressive offers choices so consumers can reach us whenever, wherever and however it’s most convenient – online at progressive.com, by phone at 1-800-PROGRESSIVE, on a mobile device or in-person with a local agent.Progressive provides insurance for personal and commercial autos and trucks, motorcycles, boats, recreational vehicles, and homes; it is the third largest auto insurer in the country, a leading seller of motorcycle and commercial...

Continue reading

Isoray’s Cesium-131 Spotlighted in Multiple Presentations at ASTRO

RICHLAND, Wash., Nov. 24, 2020 (GLOBE NEWSWIRE) — The importance of Isoray, Inc.’s (NYSE American: ISR) Cesium-131 in treating prostate and brain cancers was underscored in multiple presentations at the ASTRO 2020 annual meeting in Miami, Florida. During the virtual meeting, attendees were able to learn about the increasing body of clinical evidence showing that Cesium-131 has been found to be a valuable option in the treatment of prostate and brain cancer for clinicians and their patients.Commenting on the presentations, Isoray CEO Lori Woods said, “It is very gratifying that so many Cesium-131 studies made it through review to the meeting proceedings of the world’s leading organization in radiation oncology. A tremendous amount of work goes into each study at these respective institutions, and each illustrates a continued interest...

Continue reading

Orthopedic Devices Market to Showcase 4.3% CAGR and Hit USD 71.67 Billion by 2026; Rising Number of Knee & Hip Replacements Procedures to Spur Growth: Fortune Business Insights™

Pune, India, Nov. 24, 2020 (GLOBE NEWSWIRE) — The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures. Besides, around 30% of seniors fall per year. It is further leading to higher number of orthopedic injuries.The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period. North America procured USD 23.86 billion orthopedic medical devices market revenue in 2018. This growth is attributable to the presence of...

Continue reading

BOTS Inc. Launches Crypto Bot Software for Crypto Exchanges.

Jacksonville, Florida, Nov. 24, 2020 (GLOBE NEWSWIRE) — BOTS, Inc. (OTC: BTZI) (The “Company”) an emerging innovator of products, technologies and services for the rapidly growing cyber-security, digital robotics automation and A.I. for the manufacturing industry, announced today that together with Bots Marketplace, LLC, have developed a cryptocurrency trading bot that is simple and intuitive for crypto beginners to setup and run.“The 24/7 opening hours of the crypto market has necessitated the use of trading automation for investors that are involved in trading cryptocurrencies. Understanding this, we created CryptoBOT to help investors automate, run and manage it anytime, anywhere.” – said Paul Rosenberg, CEO of BOTS, Inc.Using familiar or popular technical indicators such as the Bollinger Band or Relative Strength Index,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.